melanoma Archives -

Regeneron pairs with BioNTech on melanoma immunotherapy

https://pharmaphorum.com/news/regeneron-pairs-with-biontech-on-melanoma-immunotherapy/

Roche’s Tecentriq claims melanoma OK, but don’t expect a sales surge

https://pharmaphorum.com/news/roches-tecentriq-claims-melanoma-ok-but-dont-expect-a-sales-surge/

Merck builds case for six-week Keytruda dosing as FDA starts review

https://pharmaphorum.com/news/merck-builds-case-for-six-week-keytruda-dosing-as-fda-starts-review/

BMS’ Opdivo/Yervoy combo hits a snag in adjuvant melanoma

https://pharmaphorum.com/news/bms-opdivo-yervoy-combo-hits-a-snag-in-adjuvant-melanoma/

UK startup Ervaxx targets ‘dark matter’ of human genome

https://pharmaphorum.com/news/uk-startup-ervaxx-targets-dark-matter-of-human-genome/

As Lyrica patent expiry looms, Pfizer buys Array for $11.4bn

https://pharmaphorum.com/news/as-lyrica-patent-expiry-looms-pfizer-buys-array-for-11-4bn/

Keytruda gets okay from FDA for adjuvant melanoma

https://pharmaphorum.com/news/keytruda-gets-okay-from-fda-for-adjuvant-melanoma/

Merck bags adjuvant okay for Keytruda in melanoma

https://pharmaphorum.com/news/merck-bags-adjuvant-okay-for-keytruda-in-melanoma/

BMS files Opdivo in post-surgery setting

https://pharmaphorum.com/news/bms-looks-licence-opdivo-suppress-melanoma-surgery/

Search